Goldman Sachs’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.1M Buy
2,235,534
+1,298,345
+139% +$10.5M ﹤0.01% 1841
2025
Q1
$7.85M Sell
937,189
-36,556
-4% -$306K ﹤0.01% 2405
2024
Q4
$7.71M Buy
973,745
+119,946
+14% +$950K ﹤0.01% 2525
2024
Q3
$7.1M Sell
853,799
-526,613
-38% -$4.38M ﹤0.01% 2515
2024
Q2
$8.77M Buy
1,380,412
+687,926
+99% +$4.37M ﹤0.01% 2192
2024
Q1
$4.2M Buy
692,486
+355,215
+105% +$2.15M ﹤0.01% 2716
2023
Q4
$2.05M Sell
337,271
-777,682
-70% -$4.72M ﹤0.01% 3194
2023
Q3
$4.71M Buy
1,114,953
+496,781
+80% +$2.1M ﹤0.01% 2516
2023
Q2
$1.92M Buy
618,172
+17,770
+3% +$55.1K ﹤0.01% 3230
2023
Q1
$835K Sell
600,402
-65,967
-10% -$91.7K ﹤0.01% 3780
2022
Q4
$1.33M Buy
666,369
+51,989
+8% +$103K ﹤0.01% 3532
2022
Q3
$1.24M Sell
614,380
-134,275
-18% -$271K ﹤0.01% 3700
2022
Q2
$2.38M Sell
748,655
-35,427
-5% -$113K ﹤0.01% 3304
2022
Q1
$3.27M Sell
784,082
-199,714
-20% -$833K ﹤0.01% 3154
2021
Q4
$4.71M Buy
983,796
+43,166
+5% +$207K ﹤0.01% 2848
2021
Q3
$5.02M Buy
940,630
+255,551
+37% +$1.36M ﹤0.01% 2793
2021
Q2
$3.51M Buy
685,079
+268,175
+64% +$1.37M ﹤0.01% 3054
2021
Q1
$2.81M Sell
416,904
-299,911
-42% -$2.02M ﹤0.01% 3093
2020
Q4
$3.28M Buy
716,815
+383,859
+115% +$1.75M ﹤0.01% 2757
2020
Q3
$1.29M Buy
332,956
+167,563
+101% +$650K ﹤0.01% 3162
2020
Q2
$788K Sell
165,393
-350,394
-68% -$1.67M ﹤0.01% 3366
2020
Q1
$1.8M Buy
515,787
+176,335
+52% +$614K ﹤0.01% 2816
2019
Q4
$1.64M Sell
339,452
-21,183
-6% -$102K ﹤0.01% 3043
2019
Q3
$1.05M Buy
360,635
+133,481
+59% +$387K ﹤0.01% 3228
2019
Q2
$1.63M Sell
227,154
-111,680
-33% -$800K ﹤0.01% 2915
2019
Q1
$4.8M Sell
338,834
-70,027
-17% -$992K ﹤0.01% 2453
2018
Q4
$5.53M Buy
408,861
+131,686
+48% +$1.78M ﹤0.01% 2252
2018
Q3
$6.15M Buy
277,175
+72,347
+35% +$1.61M ﹤0.01% 2316
2018
Q2
$3.36M Buy
+204,828
New +$3.36M ﹤0.01% 2607